Effectiveness and cost-effectiveness of RSV infant and maternal immunization programs: A case study of Nunavik, Canada

BACKGROUND: Despite passive immunization with palivizumab to select high-risk children under two years of age, the health and economic burden of respiratory syncytial virus (RSV) remains substantial. We evaluated the effectiveness and cost-effectiveness of immunization programs with new generations...

Descripción completa

Detalles Bibliográficos
Autores principales: Nourbakhsh, Shokoofeh, Shoukat, Affan, Zhang, Kevin, Poliquin, Guillaume, Halperin, Donna, Sheffield, Holden, Halperin, Scott A., Langley, Joanne M., Moghadas, Seyed M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479643/
https://www.ncbi.nlm.nih.gov/pubmed/34622186
http://dx.doi.org/10.1016/j.eclinm.2021.101141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479643/
https://www.ncbi.nlm.nih.gov/pubmed/34622186
http://dx.doi.org/10.1016/j.eclinm.2021.101141

Ejemplares similares